How does interferon exert its cell growth inhibitory effect?

European Journal of Haematology

Volumn 59, Issue 3, 1997, Pages 129-135

  Grandér, Dan ^a   Sangfelt, Olle ^a   Erickson, Sven ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apoptosis Research; Cell cycle; Cyclin; Dependent kinase inhibitors; Interferon

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; GROWTH FACTOR RECEPTOR; INTERFERON; RETINOBLASTOMA PROTEIN;

ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CELL COUNT; CELL CYCLE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CYTOTOXICITY; DRUG MECHANISM; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030820435     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1997.tb00965.x     Document Type: Review

References (48)

1. SHUAI K. Interferon-activated signal transduction to the nucleus. Curr Opinion Cell Biol 1994: 6: 253-259.
2. DE MAYER E, DE MAYER-GUIGINARD J. Interferons and Other Regulatory Cytokines. New York: John Wiley, 1988.
3. EINHORN S, STRANDER H. Interferon treatment of human malignancies - a short review. Med Oncol Tumor Pharmacother 1993: 10: 25-29.
4. PAUCKER G, CANTELL K, HENLE W. Quantitative studies on viral interference in suspended L cells. III. Effect of interfering viruses and interferon on the growth rate of the cells. Virology 1962: 17: 324-334.
5. TAYLOR-PAPADIMITRIOU J, ROZENGURT E. Interferons as regulators of cell growth and differentiation. In: TAYLOR-PAPADIMITRIOU J, ed. Interferons, Their impact In Biology and Medicine. Oxford: Oxford Medical Publications, 1985: 81.
6. BRENNING G, ÅHRE A, NILSSON K. Correlation between in vitro and in vivo sensitivity to human leukocyte interferon in patients with multiple myeloma. Scand J Haematol 1985: 35: 543-549.
7. GRANDÉR D, XU B, EINHORN S. Cytotoxic effect of interferon in primary malignant tumor cells. Studies in various malignancies. Eur J Cancer 1993: 14: 1940-1943.
8. HEYMAN M, GRANDÉR D, BRÖNDUM-NIELSEN K, et al. Interferon system defects in malignant T-cells. Leukemia 1994: 8: 425-434.
9. ROOS G, LEANDERSSON T, LUNDGREN E. Interferon-induced cell cycle changes in human hemapoietic cell lines and fresh leukemic cells. Cancer Res 1984: 44: 5358-5362.
10. LUNDBLAD D, LUNDGREN E. Block of a glioma cell line in S by interferon. Int J Cancer 1981: 27: 749-754.
11. BALKWILL F, TAYLOR-PAPDIMITRIOU J. Interferons affect both G1 and S+G2 in cells stimulated from quiescence to growth. Nature 1978: 274: 798-800.
12. TIEFENBRUN N, MELAMED D, LEVY N, et al. Alpha interferon supresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. Mol Cell Biol 1996: 16: 3934-3944.
13. GRAÑA X, REDDY EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995: 11: 211-219.
14. MORGAN DO. Principles of CDK regulation. Nature 1995: 374: 131-134.
15. KAMB A, GRUIS NA, WEAVER-FELDHAUS J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994: 264: 436-440.
16. QUELLE DE, ZINDY F, ASHMUN RA, SHERR CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995: 83: 993-1000.
17. ELBENDARY A, BERCHUCK A, DAVIS P, et al. Transforming growth factor ß1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Diff 1994: 5: 1301-1307.
18. SANGFELT O, ERICKSON S, EINHORN S, GRANDÉR D. Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-α in hematopoietic cell lines. Oncogene 1997: 14: 415-423.
19. POLYAK KJ, KATO J-Y, SOLOMON MJ, et al. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 1994: 8: 9-22.
20. Kipl) of cyclin-dependent kinase 4 activation. Cell 1994: 79: 487-496.
21. NEVINS JR. Cell cycle targets of the DNA tumor viruses. Curr Opin Gen Devel 1994: 4: 130-134.
22. PARDEE AB. G-1 events and regulation of cell proliferation. Science 1989: 246: 603-608.
23. PALMERO I, PETERS G. Perturbation of cell cycle regulators in human cancer. Cancer Surv 1996: 27: 351-367.
24. KIMCHI A. Cytokine triggered molecular pathways that control cell cycle arrest. J Cell Biochem 1992: 50: 1-9.
25. HARVAT BL, JETTEN AM. Gamma-interferon induces an irreversible growth arrest in mid-G1 in mammary epithelial cells which correlates with a block in hyperphosphorylation of retinoblastoma. Cell Growth Diff 1996: 7: 289-300.
26. HOBEIKA AC, SUBRAMANIAM PS, JOHNSON HM. IFNα induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells. Oncogene 1997: 14: 1165-1170.
27. BERGER LC, HAWLEY RG. Interferon-beta interrupts interleukin-6-dependent signaling events in myeloma cells. Blood 1997: 89: 261-271.
28. ROSENBLUM MG, MAXWELL BL, TALPAZ M, KELLEHER PJ, MCCREDIE KB, GUTTERMAN J. In vivo sensitivity and resistance of CML cells to a-IFN: correlation with receptor binding and induction of 2′, 5′-oligoadenylate synthetase. Cancer Res 1986: 46: 4848-4852.
29. GRANDÉR D, ÖBERG K, LUNDQVIST M-L, et al. Interferon-induced enhancement of 2′, 5′-oligoadenylate synthetase in mid-gut carcinoid tumors. Lancet 1990: 336: 337-339.
30. MANABE A, YI T, KUMAGAI M, CAMPARA D. Use of stroma supported cultures of leukemic cells to assess antileukemic drugs. Leukemia (Baltimore) 1993: 7: 1990-1995.
31. DEISS LP, FEINSTEIN E, BERISSI H, COHEN O, KIMCHI A. Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the γ-interferon-induced cell death. Genes Dev 1995: 9: 15-30.
32. RODRIGUEZ-VILLANUEVA J, MCDONELL TJ. Induction of apoptotic cell death in non-melanoma skin cancer by interferon-α. Int J Cancer 1995: 61: 110-114.
33. SANGFELT O, ERICKSON S, EINHORN S, CASTRO J, HEIDEN T, GRANDÉR D. Induction of apoptosis and inhibition of cell growth are independent responses of cells to interferon-α in hematopoietic cell lines. Cell Growth Diff 1997: 8: 343-352.
34. SANGFELT O, EINHORN S, BJÖRKLUND AC, WIMAN KG, OKAN I, GRANDÉR D. Wild-type p53-induced apoptosis in a Burkitt lymphoma cell line is inhibited by interferon-γ. Int J Cancer 1996: 67: 106-112.
35. MILNER AE, GRAND RJ, GREGORY CD. Effects of interferon-α on human B cells: repression of apoptosis and prevention of cell growth are independent responses of Burkitt lymphoma lines. Int J Cancer 1995: 61: 348-354.
36. WYLLIE AH. The genetic regulation of apoptosis. Curr Opinion Gen Dev 1995: 5: 97-104.
37. YANG E, KORSMEYER SJ. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 1996: 88: 386-401.
38. WHYTE M. ICE/CED-3 proteases in apoptosis. Cell Biol 1996: 6: 245-248.
39. FRASER A, EVAN G. A licence to kill. Cell 1996: 85: 781-784.
40. TANAKA N, ISHIHARA M. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 1994: 77: 829-839.
41. TAMURA T, ISHIHARA M, LAMPHIER MS. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 1995: 376: 596-599.
42. YEUNG MC, LIU J, LAU AS. An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumour necrosis factor-induced apoptosis in U937 cells. Proc Natl Acad Sci 1996: 93: 12451-12455.
43. BONG LEE S, ESTEBAN M. The interferon-induced double-stranded RNA activated protein kinase induces apoptosis. Virology 1994: 199: 491-496.
44. TAKIZAWA T, OHASHI K, NAKANISHI Y. Possible involvement of double-stranded RNA activated protein kinase in cell death by influenza virus infection. J Virol 1996: 70: 8128-8132.
45. FEINSTEIN E, WALLACH D, BOLDIN M. VARFOLOMEEV E. KIMCHI A. The death domain: a module shared by proteins with diverse cellular functions. Trends Biochem Sci 1995: 20: 342-344.
46. KISSIL JL, DEISS LP, BAYEWITCH M, RAVEH T, KHASPEKOV G. KIMCHI A. Isolation of DAP-3, a novel mediator of interferon-γ-induced cell death. J Biol Chem 1995: 270: 27932-27936.
47. DEISS LP, GALINKA H, BERISSI H, COHEN O, KIMCHI A. Cathepsin D protease mediates programmed cell death induced by IFN-γ, Fas/APO-1 and TNF-α. EMBO J 1996: 15: 3861-3870.
48. SANGFELT O, ÖSTERBORG A, GRANDÉR D, et al. Response to interferon therapy in patients with multiple myeloma correlates with the expression of the Bcl-2 oncoprotein. Int J Cancer 1995: 63: 190-192.